Abstract
The chemotherapeutic agent cis-platinum has been used effectively as a treatment for many tumors. One of the most common toxic effects caused by this treatment is ototoxicity. More severe hearing loss has been reported in patients who had received cranial radiation prior to chemotherapy with cis-platinum. The present laboratory study was undertaken with chinchillas to determine whether ototoxicity is potentiated by cis-platinum administration after cochlear irradiation. Results support the clinical observation that cranial radiation prior to administration of an ototoxic chemotherapeutic agent can have a synergistic effect of increased susceptibility to the ototoxic potential of the agent.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Volk MS, Matz GJ: Cis-platinum. Otolaryngol Head Neck Surg 91:585–587, 1983
Sexauer CL, Khan A, Burger PC, et al.: Cisplatin in recurrent pediatric brain tumors. Cancer 56:1497–1501, 1985
Taylor MH, Depetrillo AD, Turner AR: Vinblastine, bleomycin, and cisplatin in malignant germ cell tumors of the ovary. Cancer 56:1341–1349, 1985
Packer RJ, Siegel KR, Sutton LN, et al.: Results of combination chemotherapy with CCNU, VCR, and cis-plat in children with “poor-rsh’ PNET — MB. Proc of Int Soc of Ped Oncol, XVIII annual meeting, 53: 1986
Potish RA, Twiggs LB, Adcock LL, et al. Effect of cisplatinum on tolerance to radiation therapy in advanced cervical cancer. Am J Clin Oncol 9:387–391, 1986
Fenn L, Savaraj N, Ozarda AT Cisplatin in medulloblastoma with extracranial metastasis: A case report. Cancer Treat Rep 68:1307–1309, 1984
Taylor SG, Murthy AK, Showel JL, et al.: Improved control in advanced head and neck cancer with simultaneous radiation and cisplatin/5FU chemotherapy. Cancer Treat Rep 69:933–939, 1985
Granowetter L, Rosenstack J, Packer RJ: Enhanced cisplatinum neurotoxicity in pediatric patients with brain tumors. J. Neuro-Onc 1:293–297, 1983
Rubin P, The Franz Buschke lecture: Late effects of chemotherapy and radiation therapy: A new hypothesis. Int J Radiation Oncology Biol Phys 10:5–34, 1984
Konishi T, Gupta BN, Prazma J: Ototoxicity of cis-dichlorodiammine platinum (II) in guinea pigs. Am J Otolaryngol 4:18–26, 1983
Komune S, Asakuma S, Snow JB: Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum. Otolaryngol head Neck Surg 89:275–282, 1981
Nakai Y, Konishi K, Chang KC, et al.: Ototoxicity of the anticancer drug cisplatin: An experimental study. Acta Otolaryngol 93:227–232, 1982
Gamble JE, Peterson EA, Chandler JR: Radiation effects on the inner ear. Arch Otolaryn 88:64–69, 1968
Winther FO: Early degenerative changes in the inner ear sensory cells of the guinea pig following local x-ray irradiation: A preliminary report. Acta Oto-laryngologica 67:262–268, 1969
Bohne BA, Marks JE, Glasgow GP: Delayed effects of ionizing radiation on the ear. Laryngoscope 95:818–828, 1985
Baum ES, Gaynon P, Greenberg L, et al: Phase II trial of cisplatin in refractory childhood cancer: Children's cancer study group report. Cancer Treat Rep 65:818–8221, 1981
Fausti SA, Schechter MA, Rappaport BZ, et al: Early detection of cisplatin ototoxicity. Cancer 53:224–231, 1984
Schaefer SD, Post JD, Close LG, et al: Ototoxicity of low- and moderate dose cis-platin. Cancer 56:1934–1939, 1985
Khan Ab, D'Souza BJ, Wharam MD, et al: Cis-platinum therapy in recurrent childhood brain tumors. Cancer Treatment Rep 66:2013–2020, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baranak, C.C., Wetmore, R.F. & Packer, R.J. Cis-platinum ototoxicity after radiation treatment: an animal model. J Neuro-Oncol 6, 261–267 (1988). https://doi.org/10.1007/BF00163711
Issue Date:
DOI: https://doi.org/10.1007/BF00163711